Results 31 to 40 of about 104,742 (284)

Malignant pleural mesothelioma with resolution of pleural effusion

Respirology Case Reports, 2023
Key message In malignant pleural mesothelioma patients, pleural effusion may improve during the course of the disease. Pleural effusion with nodular shadows bordering the pleura should be followed up even if the pleural effusion improves.
Sayaka Nishida, Kazutoshi Toriyama, Makiko Yomota, Yukio Hosomi   +3 more
doaj   +1 more source

Management of malignant pleural effusions

Current Opinion in Pulmonary Medicine, 2011
Malignant pleural effusions (MPEs) are one of the most common problems faced by clinicians and, since there is no optimum treatment available, they deserve efforts aimed to improve their management.We have reviewed the most recent articles regarding treatment of MPE, with special emphasis on pleurodesis and indwelling pleural catheter placement ...
Rodríguez-Panadero, F., Romero-Romero, Beatriz   +1 more
openaire   +3 more sources

Malignant pleural effusion: current understanding and therapeutic approach

Respiratory Research
Malignant pleural effusion (MPE) is a common complication of thoracic and extrathoracic malignancies and is associated with high mortality and elevated costs to healthcare systems.
Francesca Gonnelli, Wafa Hassan, M. Bonifazi, Valentina Pinelli, E. Bedawi, J. M. Porcel, Najib M. Rahman, Federico Mei   +7 more
semanticscholar   +1 more source

Contemporary Approach to the Diagnosis of Malignant Pleural Effusion.

Annals of the American Thoracic Society, 2019
Advanced malignancy is a prevalent cause of exudative pleural effusion. The management of malignant pleural effusion (MPE) has been the subject of several recent randomized controlled trials and excellent reviews.
V. Kaul, D. McCracken, N. Rahman, O. Epelbaum   +3 more
semanticscholar   +1 more source

Reactive oxygen species modulator 1, a novel protein, combined with carcinoembryonic antigen in differentiating malignant from benign pleural effusion

Tumor Biology, 2017
The differential diagnosis of malignant pleural effusion and benign pleural effusion remains a clinical problem. Reactive oxygen species modulator 1 is a novel protein overexpressed in various human tumors. The objective of this study was to evaluate the
Xianmeng Chen, Na Zhang, Jiahui Dong, Gengyun Sun   +3 more
doaj   +1 more source

Cell origins and diagnostic accuracy of interleukin 27 in pleural effusions. [PDF]

PLoS ONE, 2012
The objective of the present study was to investigate the presence of interleukin (IL)-27 in pleural effusions and to evaluate the diagnostic significance of pleural IL-27.
Wei-Bing Yang, Qiu-Li Liang, Zhi-Jian Ye, Chun-Mi Niu, Wan-Li Ma, Xian-Zhi Xiong, Rong-Hui Du, Qiong Zhou, Jian-Chu Zhang, Huan-Zhong Shi   +9 more
doaj   +1 more source

Ratio of carcinoembryonic antigen in pleural fluid and serum for the diagnosis of malignant pleural effusion

Therapeutic Advances in Medical Oncology, 2019
Background: Tumour markers in pleural fluid and their diagnostic value are subject to debate. Although there are several studies on this topic, standardized cut-off values do not exist.
K. Hackner, P. Errhalt, S. Handzhiev
semanticscholar   +1 more source

Malignant pleural effusion and cancer of unknown primary site: a review of literature.

Annals of Translational Medicine, 2019
Malignant pleural effusions (MPE) are most frequently (50-65%) noted from lung and breast cancers. They are commonly unilateral and are reflective of poorer prognosis. Cancer of unknown primary (CUP) account for 4-5% of all invasive cancers.
S. Awadallah, M. Bowling, N. Sharma, A. Mohan   +3 more
semanticscholar   +1 more source

Diagnostic value of procalcitonin in pleural effusion

Egyptian Journal of Chest Disease and Tuberculosis, 2020
Background A wide range of diseases can cause pleural effusion. Its diagnosis and management remain a clinical challenge, bearing a significant cost to both patients and health care system.
Abdelsadek H Al-Aarag, Shuzan A Mohammed, Hoda Y Ibrahim, Osama I Mohammad   +3 more
doaj   +1 more source

Management of malignant pleural effusions

Current Opinion in Pulmonary Medicine, 2020
Purpose of review Malignant pleural effusion (MPE) is a common cause of breathlessness indicative of advanced disease. Treatment approaches focus on relief of breathlessness and optimizing quality of life. A number of recent, high-impact publications give further insight into the advantages of different treatment options.
Dipper, Alexandra, Bhatnagar, Rahul, Maskell, Nick   +2 more
openaire   +6 more sources